GLP-1-based meds are linked to fewer heart events in adults with obesity, autoimmune disease
byAmerican Heart AssociationCredit: Haberdoedas Photography from PexelsAmong adults with both obesity and an autoimmune disease, those taking a glucagon-like peptide-receptor 1 agonist (GLP-1RA) medic
Updated on: July 13,2026
GLP-1-based meds are linked to fewer heart events in adults with obesity, autoimmune disease
byAmerican Heart AssociationCredit: Haberdoedas Photography from PexelsAmong adults with both obesity and an autoimmune disease, those taking a glucagon-like peptide-receptor 1 agonist (GLP-1RA) medic
Updated on:July 13,2026
